These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 25274533)

  • 1. Telomere shortening: a new prognostic factor for cardiovascular disease post-radiation exposure.
    M'kacher R; Girinsky T; Colicchio B; Ricoul M; Dieterlen A; Jeandidier E; Heidingsfelder L; Cuceu C; Shim G; Frenzel M; Lenain A; Morat L; Bourhis J; Hempel WM; Koscielny S; Paul JF; Carde P; Sabatier L
    Radiat Prot Dosimetry; 2015 Apr; 164(1-2):134-7. PubMed ID: 25274533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a new multiplex quantitative real-time PCR assay for the detection of the mtDNA(4977) deletion in coronary artery disease patients: a link with telomere shortening.
    Sabatino L; Botto N; Borghini A; Turchi S; Andreassi MG
    Environ Mol Mutagen; 2013 Jun; 54(5):299-307. PubMed ID: 23703697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Telomere shortening and associated chromosomal instability in peripheral blood lymphocytes of patients with Hodgkin's lymphoma prior to any treatment are predictive of second cancers.
    M'kacher R; Bennaceur-Griscelli A; Girinsky T; Koscielny S; Delhommeau F; Dossou J; Violot D; Leclercq E; Courtier MH; Béron-Gaillard N; Assaf E; Ribrag V; Bourhis J; Feneux D; Bernheim A; Parmentier C; Carde P
    Int J Radiat Oncol Biol Phys; 2007 Jun; 68(2):465-71. PubMed ID: 17418962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening Hodgkin lymphoma survivors for radiotherapy induced cardiovascular disease.
    van Leeuwen-Segarceanu EM; Bos WJ; Dorresteijn LD; Rensing BJ; der Heyden JA; Vogels OJ; Biesma DH
    Cancer Treat Rev; 2011 Aug; 37(5):391-403. PubMed ID: 21333452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Telomere length as a potential biomarker of coronary artery disease.
    Bhattacharyya J; Mihara K; Bhattacharjee D; Mukherjee M
    Indian J Med Res; 2017 Jun; 145(6):730-737. PubMed ID: 29067974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Doses to carotid arteries after modern radiation therapy for Hodgkin lymphoma: is stroke still a late effect of treatment?
    Maraldo MV; Brodin P; Aznar MC; Vogelius IR; Munck af Rosenschöld P; Petersen PM; Specht L
    Int J Radiat Oncol Biol Phys; 2013 Oct; 87(2):297-303. PubMed ID: 23910709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Telomere shortening and ionizing radiation: a possible role in vascular dysfunction?
    Sabatino L; Picano E; Andreassi MG
    Int J Radiat Biol; 2012 Nov; 88(11):830-9. PubMed ID: 22762309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Telomere length abnormalities and telomerase RNA component expression in gastroenteropancreatic neuroendocrine tumors.
    Kim HS; Lee HS; Nam KH; Choi J; Kim WH
    Anticancer Res; 2015 Jun; 35(6):3501-10. PubMed ID: 26026117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between oxidative DNA damage and telomere shortening in circulating endothelial progenitor cells obtained from metabolic syndrome patients with coronary artery disease.
    Satoh M; Ishikawa Y; Takahashi Y; Itoh T; Minami Y; Nakamura M
    Atherosclerosis; 2008 Jun; 198(2):347-53. PubMed ID: 17983621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic factors for brain metastases after whole brain radiotherapy. Data from a single institution.
    Fleckenstein K; Hof H; Lohr F; Wenz F; Wannenmacher M
    Strahlenther Onkol; 2004 May; 180(5):268-73. PubMed ID: 15127156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive factors and prognostic effect of telomere shortening in pulmonary fibrosis.
    Planas-Cerezales L; Arias-Salgado EG; Buendia-Roldán I; Montes-Worboys A; López CE; Vicens-Zygmunt V; Hernaiz PL; Sanuy RL; Leiro-Fernandez V; Vilarnau EB; Llinás ES; Sargatal JD; Abellón RP; Selman M; Molina-Molina M
    Respirology; 2019 Feb; 24(2):146-153. PubMed ID: 30320420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive factors for radiation pneumonitis in Hodgkin lymphoma patients receiving combined-modality therapy.
    Fox AM; Dosoretz AP; Mauch PM; Chen YH; Fisher DC; LaCasce AS; Freedman AS; Silver B; Ng AK
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):277-83. PubMed ID: 22019238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiation therapy overcomes adverse prognostic role of cyclooxygenase-2 expression on Reed-Sternberg cells in early Hodgkin lymphoma.
    Mestre F; Gutiérrez A; Rodriguez J; Ramos R; Garcia JF; Martinez-Serra J; Casasus M; Nicolau C; Bento L; Herraez I; Lopez-Perezagua P; Daumal J; Besalduch J
    Int J Radiat Oncol Biol Phys; 2015 May; 92(1):84-90. PubMed ID: 25475251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Telomere length is a biomarker of cumulative oxidative stress, biologic age, and an independent predictor of survival and therapeutic treatment requirement associated with smoking behavior.
    Babizhayev MA; Savel'yeva EL; Moskvina SN; Yegorov YE
    Am J Ther; 2011 Nov; 18(6):e209-26. PubMed ID: 20228673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Shorter leukocyte telomere length is independently associated with poor survival in patients with bladder cancer.
    Russo A; Modica F; Guarrera S; Fiorito G; Pardini B; Viberti C; Allione A; Critelli R; Bosio A; Casetta G; Cucchiarale G; Destefanis P; Gontero P; Rolle L; Zitella A; Fontana D; Frea B; Vineis P; Sacerdote C; Matullo G
    Cancer Epidemiol Biomarkers Prev; 2014 Nov; 23(11):2439-46. PubMed ID: 25234236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coronary artery findings after left-sided compared with right-sided radiation treatment for early-stage breast cancer.
    Correa CR; Litt HI; Hwang WT; Ferrari VA; Solin LJ; Harris EE
    J Clin Oncol; 2007 Jul; 25(21):3031-7. PubMed ID: 17634481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Telomere dysfunction accurately predicts clinical outcome in chronic lymphocytic leukaemia, even in patients with early stage disease.
    Lin TT; Norris K; Heppel NH; Pratt G; Allan JM; Allsup DJ; Bailey J; Cawkwell L; Hills R; Grimstead JW; Jones RE; Britt-Compton B; Fegan C; Baird DM; Pepper C
    Br J Haematol; 2014 Oct; 167(2):214-23. PubMed ID: 24990087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Telomere shortening in human coronary artery diseases.
    Ogami M; Ikura Y; Ohsawa M; Matsuo T; Kayo S; Yoshimi N; Hai E; Shirai N; Ehara S; Komatsu R; Naruko T; Ueda M
    Arterioscler Thromb Vasc Biol; 2004 Mar; 24(3):546-50. PubMed ID: 14726417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thyroid exposure to scattered radiation and associated second cancer risk from paediatric radiotherapy for extracranial tumours.
    Mazonakis M; Kourinou K; Lyraraki E; Varveris H; Damilakis J
    Radiat Prot Dosimetry; 2012 Dec; 152(4):317-22. PubMed ID: 22504308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cumulative absolute breast cancer risk for young women treated for Hodgkin lymphoma.
    Travis LB; Hill D; Dores GM; Gospodarowicz M; van Leeuwen FE; Holowaty E; Glimelius B; Andersson M; Pukkala E; Lynch CF; Pee D; Smith SA; Van't Veer MB; Joensuu T; Storm H; Stovall M; Boice JD; Gilbert E; Gail MH
    J Natl Cancer Inst; 2005 Oct; 97(19):1428-37. PubMed ID: 16204692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.